Article History
First Online: 28 January 2020
Compliance with Ethical Standards
:
: No sources of funding were used to prepare this manuscript.
: F Sellebjerg has served on scientific advisory boards, been on steering committees of clinical trials, served as a consultant, received support for congress participation, received speaker honoraria, or received research support for his laboratory from Biogen, Merck, Novartis, Roche, Sanofi Genzyme, and Teva. M. Blinkenberg has received personal compensation for serving on scientific advisory boards for Genzyme, Roche, Biogen, Merck, Novartis, and Teva; has received speaker honoraria from Genzyme, Biogen, Merck, Novartis, Teva, and Roche; has received consulting honoraria from the Danish Multiple Sclerosis Society, Biogen, Teva, Roche, and Merck; and has received funding for travel from Genzyme, Roche, and Biogen. P. S. Sorensen has received personal compensation for serving on scientific advisory boards, steering committees, or independent data monitoring boards for Biogen, Merck, Novartis, Teva, GlaxoSmithKline, MedDay Pharmaceuticals, Genzyme, Celgene, and Forward Pharma, and has received speaker honoraria from Biogen, Merck, Teva, Genzyme, and Novartis.